Agarwal, A
MacKenzie, R J
Eide, C A
Davare, M A
Watanabe-Smith, K
Tognon, C E
Mongoue-Tchokote, S
Park, B
Braziel, R M
Tyner, J W
Druker, B J
Article History
Received: 22 February 2014
Revised: 23 May 2014
Accepted: 15 June 2014
First Online: 11 August 2014
Competing interests
: OHSU and BJD have a financial interest in Molecular MD (5% equity or less). This potential conflict of interest has been reviewed and managed by the OHSU Conflict of Interest in Research Committee and the Integrity Program Oversight Council. OHSU has clinical trial contracts with Novartis, and Bristol Myers Squibb to pay for patient costs, nurse and data manager salaries and institutional overhead. BJD does not derive salary, nor do their laboratories receive funds, from these contracts. BJD serves as a consultant for Roche and Nodality (Consulting income $10,000 or over).